메트로니다졸(Metronidazole) 시장 보고서(2025년)

Metronidazole is an antibiotic and antiprotozoal medication used to treat bacterial and parasitic infections. It functions by penetrating microbial cells, where bacterial and protozoal enzymes reduce it, producing reactive nitrogen species. These reactive compounds damage DNA, leading to strand breakage and the inhibition of nucleic acid synthesis, ultimately disrupting replication and transcription, resulting in cell death.

The primary formulations of metronidazole include tablets, capsules, intravenous (IV) solutions, topical creams or ointments, and others. Metronidazole tablets are oral medications used to treat bacterial and parasitic infections, providing sustained effects for convenient and effective outpatient treatment. They are utilized for various applications, including bacterial infections, parasitic infections, gynecological infections, surgical prophylaxis, and more. The drug is distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used by various end-users, including hospitals, clinics, homecare, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The metronidazole market research report is one of a series of new reports from The Business Research Company that provides metronidazole market statistics, including the metronidazole industry global market size, regional shares, competitors with the metronidazole market share, detailed metronidazole market segments, market trends, and opportunities, and any further data you may need to thrive in the metronidazole industry. This metronidazole market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The metronidazole market size has grown strongly in recent years. It will grow from $0.58 billion in 2024 to $0.61 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to favorable healthcare reimbursement policies, increasing funding for infectious disease research, a growing incidence of oral and dental infections, a rising prevalence of inflammatory bowel diseases, and a growing elderly population.

The metronidazole market size is expected to see strong growth in the next few years. It will grow to $0.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to the increasing prevalence of bacterial and protozoal infections, rising cases of gastrointestinal disorders, growing demand for affordable generic antibiotics, expanding healthcare infrastructure, and government initiatives to combat infectious diseases. Major trends in the forecast period include advancements in pharmaceutical manufacturing, strategic collaborations between pharmaceutical companies, expansion of pharmaceutical contract manufacturing organizations, adoption of nanotechnology-based drug delivery systems, and advancements in pH-responsive metronidazole formulations.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. pharmacies by driving up the cost of nitroimidazole antibiotic bulk active pharmaceutical ingredient and compounded topical formulations imported from China and Italy, exacerbating parasitic and anaerobic infection treatment costs and increasing retail prescription prices. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of bacterial infections is expected to drive the growth of the metronidazole market. Bacterial infections occur due to the proliferation of harmful bacteria in the body, and their increasing prevalence is attributed to factors such as antibiotic resistance, environmental changes, and a growing immunocompromised population. Metronidazole works by targeting bacterial DNA, disrupting its replication and spread, making it highly effective against anaerobic bacteria and certain protozoal infections. For instance, according to the UK Health Security Agency (UKHSA), a UK-based government agency, an estimated 58,224 individuals in England were affected by antibiotic-resistant infections in 2022, marking a 4% increase from 55,792 cases in 2021. Additionally, deaths from severe antibiotic-resistant infections rose from 2,110 in 2021 to 2,202 in 2022. As a result, the growing prevalence of bacterial infections is expected to fuel the expansion of the metronidazole market.

Key players in the metronidazole market are focusing on advancing drug formulations to improve patient compliance. Innovations such as ready-to-use oral liquids are being developed to enhance ease of administration, particularly for patients who have difficulty swallowing tablets or require a more convenient treatment option. Ready-to-use oral liquids eliminate the need for additional preparation or mixing, simplifying medication adherence. For example, in November 2023, Kesin Pharma Corporation, a US-based specialty pharmaceutical company, received FDA approval for LIKMEZ (metronidazole) oral suspension, 500 mg/5 mL. This novel formulation is designed to improve patient adherence and is approved for treating trichomoniasis and anaerobic bacterial infections in adults, as well as amebiasis in adults and children. LIKMEZ is available as a strawberry peppermint-flavored suspension in a 200 mL bottle with a 24-month shelf life and does not require refrigeration.

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired a manufacturing facility from Teva Pharmaceutical Industries for an undisclosed amount. This acquisition is expected to double Marksans' existing production capacity from 8 billion units per year. Teva Pharmaceutical Industries is an India-based pharmaceutical company that manufactures metronidazole tablets.

Major players in the metronidazole market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Fresenius Kabi AG, Baxter International Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Lupin Pharmaceuticals Inc., Zydus Lifesciences, YiChang HEC ChangJiang Pharmaceutical Co. Ltd., Aarti Drugs Ltd., Unichem Laboratories, Cosette Pharmaceuticals Inc., Saptalis Pharmaceuticals LLC, Huanggang Saikang Pharmaceutical Co. Ltd., Kesin Pharma, Hubei Hongyuan Pharmaceutical Technology Co. Ltd., Huanggang Yinhe Aarti Pharmaceutical Co. Ltd., and Higgs Healthcare.

Asia-Pacific was the largest region in the metronidazole market in 2024. The regions covered in metronidazole report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metronidazole market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metronidazole market consists of sales of oral suspension, suppositories, and gel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metronidazole Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metronidazole market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metronidazole ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metronidazole market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation Type: Tablets; Capsules; Intravenous (IV) Solutions; Topical Creams Or Ointments; Other Formulation Types
• 2) By Application: Bacterial Infections; Parasitic Infections; Gynecological Infections; Surgical Prophylaxis; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By End-User: Hospitals; Clinics; Homecare; Other End Users
• Subsegments:
• 1) By Tablets: Immediate Release Tablets; Extended Release Tablets
• 2) By Capsules: Immediate Release Capsules; Extended Release Capsules
• 3) By Intravenous (IV) Solutions: Single-dose IV Solutions; Multi-dose IV Solutions
• 4) By Topical Creams Or Ointments: Topical Creams; Topical Ointments
• 5) By Other Formulation Types: Oral Suspension; Vaginal Gels Or Suppositories
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Abbott Laboratories; Fresenius Kabi AG; Baxter International Inc.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Limited; Cipla Limited; Dr. Reddy's Laboratories Ltd.; Lupin Pharmaceuticals Inc.; Zydus Lifesciences; YiChang HEC ChangJiang Pharmaceutical Co. Ltd.; Aarti Drugs Ltd.; Unichem Laboratories; Cosette Pharmaceuticals Inc.; Saptalis Pharmaceuticals LLC; Huanggang Saikang Pharmaceutical Co. Ltd.; Kesin Pharma; Hubei Hongyuan Pharmaceutical Technology Co. Ltd.; Huanggang Yinhe Aarti Pharmaceutical Co. Ltd.; Higgs Healthcare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metronidazole Market Characteristics

3. Metronidazole Market Trends And Strategies

4. Metronidazole Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metronidazole Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metronidazole PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metronidazole Market Growth Rate Analysis
• 5.4. Global Metronidazole Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metronidazole Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metronidazole Total Addressable Market (TAM)

6. Metronidazole Market Segmentation

• 6.1. Global Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Intravenous (IV) Solutions
• Topical Creams Or Ointments
• Other Formulation Types
• 6.2. Global Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Infections
• Parasitic Infections
• Gynecological Infections
• Surgical Prophylaxis
• Other Applications
• 6.3. Global Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Metronidazole Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End User
• 6.5. Global Metronidazole Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate Release Tablets
• Extended Release Tablets
• 6.6. Global Metronidazole Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate Release Capsules
• Extended Release Capsules
• 6.7. Global Metronidazole Market, Sub-Segmentation Of Intravenous (IV) Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-dose IV Solutions
• Multi-dose IV Solutions
• 6.8. Global Metronidazole Market, Sub-Segmentation Of Topical Creams Or Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Creams
• Topical Ointments
• 6.9. Global Metronidazole Market, Sub-Segmentation Of Other Formulation Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Suspension
• Vaginal Gels Or Suppositories

7. Metronidazole Market Regional And Country Analysis

• 7.1. Global Metronidazole Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metronidazole Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metronidazole Market

• 8.1. Asia-Pacific Metronidazole Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metronidazole Market

• 9.1. China Metronidazole Market Overview
• 9.2. China Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metronidazole Market

• 10.1. India Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metronidazole Market

• 11.1. Japan Metronidazole Market Overview
• 11.2. Japan Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metronidazole Market

• 12.1. Australia Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metronidazole Market

• 13.1. Indonesia Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metronidazole Market

• 14.1. South Korea Metronidazole Market Overview
• 14.2. South Korea Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metronidazole Market

• 15.1. Western Europe Metronidazole Market Overview
• 15.2. Western Europe Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metronidazole Market

• 16.1. UK Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metronidazole Market

• 17.1. Germany Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metronidazole Market

• 18.1. France Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metronidazole Market

• 19.1. Italy Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metronidazole Market

• 20.1. Spain Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metronidazole Market

• 21.1. Eastern Europe Metronidazole Market Overview
• 21.2. Eastern Europe Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metronidazole Market

• 22.1. Russia Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metronidazole Market

• 23.1. North America Metronidazole Market Overview
• 23.2. North America Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metronidazole Market

• 24.1. USA Metronidazole Market Overview
• 24.2. USA Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metronidazole Market

• 25.1. Canada Metronidazole Market Overview
• 25.2. Canada Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metronidazole Market

• 26.1. South America Metronidazole Market Overview
• 26.2. South America Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metronidazole Market

• 27.1. Brazil Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metronidazole Market

• 28.1. Middle East Metronidazole Market Overview
• 28.2. Middle East Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metronidazole Market

• 29.1. Africa Metronidazole Market Overview
• 29.2. Africa Metronidazole Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metronidazole Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metronidazole Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metronidazole Market Competitive Landscape And Company Profiles

• 30.1. Metronidazole Market Competitive Landscape
• 30.2. Metronidazole Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metronidazole Market Other Major And Innovative Companies

• 31.1. Sandoz Group AG
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Aurobindo Pharma Limited
• 31.4. Cipla Limited
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Lupin Pharmaceuticals Inc.
• 31.7. Zydus Lifesciences
• 31.8. YiChang HEC ChangJiang Pharmaceutical Co. Ltd.
• 31.9. Aarti Drugs Ltd.
• 31.10. Unichem Laboratories
• 31.11. Cosette Pharmaceuticals Inc.
• 31.12. Saptalis Pharmaceuticals LLC
• 31.13. Huanggang Saikang Pharmaceutical Co. Ltd.
• 31.14. Kesin Pharma
• 31.15. Hubei Hongyuan Pharmaceutical Technology Co. Ltd.

32. Global Metronidazole Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metronidazole Market

34. Recent Developments In The Metronidazole Market

35. Metronidazole Market High Potential Countries, Segments and Strategies

• 35.1 Metronidazole Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metronidazole Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metronidazole Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer